Cancer: clinical trials and information
Cancer clinical trials in Canada
| Phase | Provinces | ||||
|---|---|---|---|---|---|
| Virtual Reality as an Adjunct to Management of Pain and Anxiety in Palliative Care NCT04138095 | Unknown status | Not applicable | Manitoba | Riverview Health Centre | 2020-10-01 |
| Cannabis Oil for Pain Effectiveness NCT03522467 | Unknown status | Phase 2 | Ontario | Aurora Cannabis Inc | 2018-07-25 |
| Safety and Efficacy of Smoked Cannabis for Improving Quality of Life in Advanced Cancer Patients NCT03339622 | Terminated | Phase 3 | Quebec | Tetra Bio-Pharma | 2018-03-29 |
| Immersive Multimedia as an Adjunctive Measure for Pain Control in Cancer Patients NCT02995434 | Completed | Not applicable | British Columbia | University of British Columbia | 2017-07-31 |
| Online MBSR Program for Cancer Survivors With Chronic Neuropathic Pain NCT02758197 | Completed | Not applicable | Ontario | Ottawa Hospital Research Institute | 2016-07 |
| Patient-Centred Innovations for Persons With Multimorbidity - Quebec NCT02789800 | Completed | Not applicable | Quebec | Université de Sherbrooke | 2016-04-22 |
| Patient-Centred Innovations for Persons With Multimorbidity - Ontario NCT02742597 | Completed | Not applicable | Ontario | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2016-01-12 |
| PECBLOCK for the Treatment of Pain After Breast Surgery NCT01670448 | Completed | Not applicable | Quebec | Centre hospitalier de l'Université de Montréal (CHUM) | 2014-01 |
| A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. NCT00530764 | Completed | Phase 2 | British Columbia, Quebec | GW Pharmaceuticals Ltd | 2007-11 |
| A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer NCT00381095 | Terminated | Phase 4 | Ontario | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2006-12 |
Cancer clinical trials worldwide (outside Canada)
36 trials, 5 recruiting or not yet recruiting. Recruiting first.
About Cancer
What is Cancer?
Cancer-related pain can come from a tumour pressing on bones, nerves or organs, or from cancer treatments such as surgery, chemotherapy or radiation. It can be short-term or long-lasting.
How is Cancer usually assessed?
Cancer care teams usually assess pain regularly using rating scales and questions about where it is, how it feels and how it affects daily life.
What kinds of treatments are studied for Cancer?
Registered studies cover medicines, medical devices (such as nerve stimulators), procedures (such as nerve blocks or injections), physical and movement therapies, psychological approaches (such as cognitive behavioural therapy), education programs and digital tools. Being studied in a trial does not mean a treatment works or is approved. The interventions listed on this page come directly from the registry records.
How can I find Cancer clinical trials in Canada?
This page lists 10 registry records for this term with at least one site in Canada, recruiting studies first. Each trial page links to the official ClinicalTrials.gov record, which lists the study contacts. Recruiting status changes often, so check the registry, and talk to your doctor before joining a study.
Related conditions
Related interventions
- Drug: placebo (2)
- Drug: Oxycodone (2)
- Drug: Oxycodone/Naloxone (2)
- Drug: Ziconotide (1)
- Procedure: management of therapy complications (1)
- Procedure: pain therapy (1)
- Drug: pregabalin (1)
- Drug: Oxymorphone Extended Release (1)
- Drug: Fentanyl (1)
- Drug: Tapentadol Prolonged Release (1)
- Drug: Ketamine Hydrochloride (1)
- Other: Questionnaire Administration (1)
- Procedure: assessment of therapy complications (1)
- Procedure: quality-of-life assessment (1)
- Other: Control (1)
- Other: Questionnaires (1)
- Behavioral: Empowered Relief (1)
Related US FDA drug labels
Labels whose indications text mentions this term. US labels, not Health Canada Product Monographs.
- Symproic
- Lubiprostone capsules
- Dehydrated Alcohol Injection
- FDA drug label 1d0a512a
- Dehydrated Alcohol Injection
- Lubiprostone capsules
- Dehydrated Alcohol Injection, USP
- Dehydrated Alcohol Injection, USP
- Dehydrated Alcohol Injection
- Dehydrated Alcohol Injection
- Dehydrated Alcohol Injection
- FDA drug label 5437ccae
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.